Fig. 6. Her5 activates cell proliferation within the MH domain, but this process is
in itself insufficient to account for the regulation of ngn1
expression. (A,F) her5 expression (in situ hybridization, blue
staining) and density of cells in M phase (brown anti-phosphoH3
immunostaining) (in number of positive cells per cell row) in the anterior
neural plate at the 3-somite stage (in territories schematized in A) in
hsp-her5 transgenics (C), their wild-type siblings (B) (both
heat-shocked), wild-type (D) and MOher5-injected embryos (E). A is
a schematic representation of the neural plate in B,C; B-E are flat-mounted
views of the anterior neural plate (B,C) or the endogenous her5
domain (D,E), anterior to the top. White arrow in B,C, the endogenous domain
of her5 expression (territories A + B); box in D,E indicates
territory A. Proliferation is enhanced in territory A compared to other neural
plate domains in wild-type embryos (brown arrows in B,D). Her5 is sufficient
to increase proliferation within the MH domain upon ectopic expression
(territories A-D) (F, left panel), and is necessary for the increased level of
proliferation of territory A (F, right panel). (G-J) Expression of the
cyclin-dependent kinase inhibitor-encoding gene p27Xic1-a
is downregulated by Her5 within the IZ. Expression of
p27Xic1-a and pax2.1, as indicated (bottom left,
color-coded), in hsp-her5 transgenic embryos after heat-shock (H) and
MOher5-injected embryos (J) compared to their wild-type siblings
(G,I) at the 3-somite stage. In the vcc and IZ, p27Xic1-a
expression is strikingly similar to that of ngn1 (e.g.
Fig. 3D).
p27Xic1-a expression is down-regulated within the neural
plate following ectopic her5 expression (arrow in H), and is
activated across the IZ when Her5 activity is blocked (white arrows in J).
Concomitantly in the latter case, p27Xic1-a expression is
partially reduced in the vcc area, a phenomenon at present unexplained but
independent of cell migration (A.G. and L.B.-C., unpublished data). (K-N) The
direct inhibition of cell proliferation does not affect IZ formation and
her5 expression. Expression of ngn1 or her5 (blue
in situ hybridization staining) and anti-phosphoH3 immunostaining (brown
nuclei) at the 3-somite stage in embryos treated with the cell proliferation
inhibitor aphidicolin at the onset of neurogenesis (L,N) compared to
mock-treated siblings (K,M). Although phosphoH3 staining is virtually
abolished upon aphidicolin treatment, both IZ size (bracket in K,L) and
her5 expression appear normal. Aphi, aphidicholin-treated embryo; hs,
heat-shocked embryo; IZ, intervening zone; tg, transgenic; vcc, ventrocaudal
cluster.